乌帕替尼治疗红皮病型银屑病1例

徐 晨, 王再 兴*
安徽医科大学第一附属医院皮肤科

摘要


报告1例乌帕替尼成功治疗红皮病型银屑病。患者女，70岁。四肢、躯干及颜面部弥漫性红斑脱屑半年，加重伴肿胀发热10天。皮肤科检查：周身弥漫性潮红肿胀脱屑，皮肤褶皱处可见少量渗出。完善组织病理及相关检验检查，诊断：红皮病型银屑病。治疗：予以口服乌帕替尼15mg，每日2次，治疗15天后皮损显著消退。

关键词


乌帕替尼；红皮病型银屑病；JAK抑制剂；治疗

全文:

PDF


参考


[1]Nair, P.A. and T. Badri, Psoriasis, in StatPearls. 2025, StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.: Treasure Island (FL).

[2]Singh, R.K., et al., Erythrodermic psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl), 2016. 6: p. 93-104.

[3]Zhang, P., et al., Analysis of Th1/Th2 response pattern for erythrodermic psoriasis. J Huazhong Univ Sci Technolog Med Sci, 2014. 34(4): p. 596-601.

[4]Charbit, L., et al., Systemic treatments in childhood psoriasis: a French multicentre study on 154 children. Br J Dermatol, 2016. 174(5): p. 1118-21.

[5]Shao, S., et al., Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances. Drugs, 2020. 80(6): p. 525-534.

[6]Mastorino, L., et al., Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review. Am J Clin Dermatol, 2025.

[7]Boyd, A.S. and A. Menter, Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol, 1989. 21(5 Pt 1): p. 985-91.

[8]Di Meglio, P. and J.H. Duarte, CD8 T Cells and IFN-γ emerge as critical players for psoriasis in a novel model of mouse psoriasiform skin inflammation. J Invest Dermatol, 2013. 133(4): p. 871-4.

[9]Mohamed, M.F., et al., Upadacitinib: Mechanism of action, clinical, and translational science. Clin Transl Sci, 2024. 17(1): p. e13688.


Refbacks

  • 当前没有refback。